RE: Statements in House6 Jul 2021 20:36
On the EU deal all we know is still ongoing. Who knows, but until we're told it is or isn't that's it.
FDA is excruciatingly frustrating, but we do know the kit has passed other national approvals and academic studies (including the New Mexico one in the good old US of A) with flying colours. It should come, but the FDA take their own time and sure are doing that. Mind you, it should blow the socks off this if/when
We don't know if BC have made leads there yet (given they can already sell to a somewhat smaller market in US without), but I'd be surprised if there's nothing going on out there
And yeah, the co communicate like they're main market not aim, but look recently we have had India approval & licence, and the Covid PoC's working
Let's have AIHL now, given it's already CE marked, in PHE framework, medical guidance has been updated to recommend testing prior to antibiotic use in infants, and it's been extensively trialled successfully in two NHS hospitals already it SHOULD hit the ground running
Look, I admit I'm pretty done with hearing frustrations ad nauseam from a couple of posters, and no apologies for saying that. I'm invested too, and I know why. I think the position is excellent here, my view